{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:26:58Z","timestamp":1794212818228,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004767","name":"University of Science and Technology Liaoning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010018","name":"Doctoral Scientific Research Start-up Project of Liaoning Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024-BSLH-331"],"award-info":[{"award-number":["2024-BSLH-331"]}],"id":[{"id":"10.13039\/501100010018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.intimp.2026.117520","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:36:03Z","timestamp":1791635763000},"page":"117520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Molecular mechanism of S100A11 inhibiting anti-HCC immune function of NK cells"],"prefix":"10.1016","volume":"190","author":[{"given":"Xiuli","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanhui","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianbao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2026.117520_bb0005","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.ymthe.2025.02.013","article-title":"A BPTF-specific PROTAC degrader enhances NK cell-based cancer immunotherapy","volume":"33","author":"Li","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.intimp.2026.117520_bb0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-3-030-49270-0_4","article-title":"NK cells in the tumor microenvironment","volume":"1273","author":"Guillerey","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2026.117520_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.775462","article-title":"Targeting immune cells in the tumor microenvironment of HCC: new opportunities and challenges","volume":"9","author":"Hao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117520_bb0020","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/hep.26192","article-title":"Monocyte\/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48\/2B4 interactions","volume":"57","author":"Wu","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.intimp.2026.117520_bb0025","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.clim.2008.08.012","article-title":"Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients","volume":"129","author":"Cai","year":"2008","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117520_bb0030","first-page":"17","article-title":"Diminished absolute counts of CD56dim and CD56bright natural killer cells in peripheral blood from Egyptian patients with hepatocellular carcinoma","volume":"16","author":"Fathy","year":"2009","journal-title":"Egypt. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117520_bb0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/gutjnl-2011-300509","article-title":"Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma","volume":"61","author":"Chew","year":"2012","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.intimp.2026.117520_bb0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3799","article-title":"Balancing natural killer cell activation through paired receptors","volume":"15","author":"Martinet","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117520_bb0045","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.3390\/cancers13092184","article-title":"Natural killer-dendritic cell interactions in liver cancer: implications for immunotherapy","volume":"13","author":"Cazzetta","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2026.117520_bb0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu","year":"2020","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2026.117520_bb0055","doi-asserted-by":"crossref","first-page":"318","DOI":"10.7150\/ijms.80503","article-title":"S100A11 promotes metastasis via AKT and ERK signaling pathways and has a diagnostic role in hepatocellular carcinoma","volume":"20","author":"Zheng","year":"2023","journal-title":"Int. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.117520_bb0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/gutjnl-2024-332193","article-title":"Microbiota-induced S100A11-RAGE axis underlies immune evasion in right-sided colon adenomas and is a therapeutic target to boost anti-PD1 efficacy","volume":"74","author":"Zhou","year":"2025","journal-title":"Gut"},{"issue":"13","key":"10.1016\/j.intimp.2026.117520_bb0065","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161713","article-title":"Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression","volume":"133","author":"Gou","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2026.117520_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.7150\/jca.78011","article-title":"S100A11: a potential carcinogen and prognostic marker that correlates with the immunosuppressive microenvironment in Pan-Cancer","volume":"14","author":"Ji","year":"2023","journal-title":"J. Cancer"},{"issue":"16","key":"10.1016\/j.intimp.2026.117520_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70016","article-title":"Raddeanin A augments the cytotoxicity of natural killer cells against chronic myeloid leukaemia cells by modulating MAPK and Ras\/Raf signalling pathways","volume":"28","author":"Hsieh","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.intimp.2026.117520_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115636","article-title":"Isolation, structural elucidation and immuno-stimulatory properties of polysaccharides from Cuminum cyminum","volume":"230","author":"Tabarsa","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"5","key":"10.1016\/j.intimp.2026.117520_bb0085","first-page":"697","article-title":"Carfilzomib activates ER stress and JNK\/p38 MAPK signaling to promote apoptosis in hepatocellular carcinoma cells","volume":"56","author":"Deng","year":"2024","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.intimp.2026.117520_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1502270","article-title":"Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma","volume":"14","author":"Huang","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.117520_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1651129","article-title":"TGF-\u03b2-driven NK cells plasticity in hepatocellular carcinoma","volume":"16","author":"Reverberi","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2026.117520_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70773","article-title":"Emerging immune-based therapeutic strategies in hepatocellular carcinoma","volume":"46","author":"Kah","year":"2026","journal-title":"Liver Int."},{"issue":"904","key":"10.1016\/j.intimp.2026.117520_bb0105","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adq8778","article-title":"Interleukins 15 and 18 synergistically prime the antitumor function of natural killer cells through noncanonical activation of mTORC1","volume":"18","author":"Fallone","year":"2025","journal-title":"Sci. Signal."},{"key":"10.1016\/j.intimp.2026.117520_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115531","article-title":"Helixor a enhances natural killer cell activity by induction of PAI-1 expression through the p38\/MAPK signaling pathway","volume":"165","author":"Lee","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117520_bb0115","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41568-025-00836-5","article-title":"Endoplasmic reticulum stress responses in anticancer immunity","volume":"25","author":"Hwang","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"16","key":"10.1016\/j.intimp.2026.117520_bb0120","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.7150\/ijms.120874","article-title":"Endoplasmic reticulum stress in Cancer progression: a comprehensive review of its role and mechanisms","volume":"22","author":"Yu","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.intimp.2026.117520_bb0125","doi-asserted-by":"crossref","DOI":"10.1177\/10732748261433283","article-title":"Overexpression of S100 calcium-binding protein A2 is associated with poor prognosis in hepatocellular carcinoma","volume":"33","author":"Chen","year":"2026","journal-title":"Cancer Control"},{"issue":"17","key":"10.1016\/j.intimp.2026.117520_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18172848","article-title":"Amplification-driven S100A11 overexpression in hepatocellular carcinoma is associated with metabolic reprogramming, ECM remodelling, and immune evasion: a pan-cancer genomic study","volume":"18","author":"Lutimba","year":"2026","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.intimp.2026.117520_bb0135","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3748\/wjg.v29.i6.1054","article-title":"Immunotherapy for hepatocellular carcinoma: current status and future perspectives","volume":"29","author":"Mandlik","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117520_bb0140","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-020-01222-5","article-title":"Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.117520_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1454427","article-title":"Efficacy and safety of natural killer cell therapy in patients with solid tumors: a systematic review and meta-analysis","volume":"15","author":"Park","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117520_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1525567","article-title":"The multi-faceted immune modulatory role of S100A4 in cancer and chronic inflammatory disease","volume":"16","author":"Wong","year":"2025","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117520_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70387","article-title":"Natural killer cell-mediated antitumor immunity: molecular mechanisms and clinical applications","volume":"6","author":"Luo","year":"2025","journal-title":"MedComm"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:16:00Z","timestamp":1794212160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926013688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":31,"alternative-id":["S1567576926013688"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117520","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanism of S100A11 inhibiting anti-HCC immune function of NK cells","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117520"}}